CBHD.XETRA Coloplast A/S

Healthcare Health Care Equipment & Supplies XETRA Stock Exchange
72.86 EUR
Close of Nov 6, 2026
49.48 78.07
Market cap
EUR 15.1B
P/E
36.6x
P/B
8.18x
ROE
21.5%
Dividend yield
4.44%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Sep 2026.

Is CBHD.XETRA undervalued?

Graham number

The Graham number of Coloplast A/S cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Coloplast A/S fundamental analysis

No fundamental analysis for Coloplast A/S yet.

Coloplast A/S stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of osto…

Full company profile